MYT Netherlands Parent B.V.

NYSE:MYTE Stock Report

Market Cap: US$538.9m

MYT Netherlands Parent B.V Valuation

Is MYTE undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of MYTE when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: MYTE ($7.23) is trading above our estimate of fair value ($2.11)

Significantly Below Fair Value: MYTE is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for MYTE?

Key metric: As MYTE is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for MYTE. This is calculated by dividing MYTE's market cap by their current revenue.
What is MYTE's PS Ratio?
PS Ratio0.7x
Sales€855.09m
Market Cap€512.10m

Price to Sales Ratio vs Peers

How does MYTE's PS Ratio compare to its peers?

The above table shows the PS ratio for MYTE vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average0.5x
REAL RealReal
0.8x10.1%US$473.9m
LE Lands' End
0.3x-0.2%US$461.7m
JILL J.Jill
0.6x1.6%US$368.4m
CURV Torrid Holdings
0.4x0.8%US$414.5m
MYTE MYT Netherlands Parent B.V
0.7x9.2%US$538.9m

Price-To-Sales vs Peers: MYTE is expensive based on its Price-To-Sales Ratio (0.7x) compared to the peer average (0.5x).


Price to Sales Ratio vs Industry

How does MYTE's PS Ratio compare vs other companies in the US Specialty Retail Industry?

43 CompaniesPrice / SalesEstimated GrowthMarket Cap
TA TravelCenters of America
0.1x-0.8%US$1.30b
ODP ODP
0.1x-2.1%US$777.35m
ARKO Arko
0.09x-1.7%US$758.30m
GCO Genesco
0.1x1.9%US$331.04m
MYTE 0.7xIndustry Avg. 0.4xNo. of Companies43PS00.61.21.82.43+
43 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: MYTE is expensive based on its Price-To-Sales Ratio (0.7x) compared to the US Specialty Retail industry average (0.4x).


Price to Sales Ratio vs Fair Ratio

What is MYTE's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

MYTE PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.7x
Fair PS Ratio0.5x

Price-To-Sales vs Fair Ratio: MYTE is expensive based on its Price-To-Sales Ratio (0.7x) compared to the estimated Fair Price-To-Sales Ratio (0.5x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst MYTE forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$7.23
US$5.66
-21.8%
25.4%US$7.96US$3.82n/a5
Nov ’25US$6.23
US$4.75
-23.8%
13.0%US$5.62US$4.03n/a5
Oct ’25US$3.65
US$4.75
+30.1%
13.0%US$5.62US$4.03n/a5
Sep ’25US$3.73
US$4.95
+32.6%
10.5%US$5.64US$4.02n/a5
Aug ’25US$3.89
US$4.90
+25.9%
10.5%US$5.57US$3.97n/a5
Jul ’25US$5.07
US$4.90
-3.4%
10.5%US$5.57US$3.97n/a5
Jun ’25US$5.37
US$4.91
-8.5%
10.5%US$5.60US$3.99n/a5
May ’25US$4.13
US$3.93
-4.8%
15.8%US$4.91US$2.97n/a5
Apr ’25US$3.52
US$3.94
+12.1%
17.1%US$5.05US$3.02n/a5
Mar ’25US$3.46
US$3.93
+13.5%
18.8%US$5.04US$3.02n/a7
Feb ’25US$2.56
US$3.95
+54.1%
20.2%US$5.09US$2.99n/a7
Jan ’25US$3.19
US$4.30
+34.7%
26.6%US$6.58US$3.01n/a8
Dec ’24US$3.25
US$4.30
+32.4%
27.1%US$6.51US$2.98n/a8
Nov ’24US$2.93
US$5.17
+76.5%
21.0%US$7.82US$3.99US$6.238
Oct ’24US$3.40
US$5.17
+52.1%
21.0%US$7.82US$3.99US$3.658
Sep ’24US$3.73
US$6.28
+68.4%
25.6%US$8.02US$3.40US$3.738
Aug ’24US$4.11
US$6.70
+63.0%
17.7%US$7.99US$4.01US$3.898
Jul ’24US$4.00
US$6.70
+67.5%
17.7%US$7.99US$4.01US$5.078
Jun ’24US$4.08
US$9.38
+129.9%
47.8%US$19.51US$5.95US$5.378
May ’24US$4.87
US$10.11
+107.5%
43.6%US$19.81US$6.05US$4.138
Apr ’24US$7.03
US$13.84
+96.8%
32.4%US$21.29US$7.19US$3.528
Mar ’24US$8.27
US$13.96
+68.8%
25.1%US$20.71US$9.05US$3.469
Feb ’24US$11.44
US$16.32
+42.7%
22.2%US$21.19US$9.03US$2.569
Jan ’24US$8.91
US$16.69
+87.4%
19.3%US$20.90US$10.62US$3.199
Dec ’23US$9.44
US$16.69
+76.8%
18.3%US$20.34US$10.34US$3.258
Nov ’23US$11.72
US$16.55
+41.2%
17.7%US$20.27US$9.99US$2.938

Analyst Forecast: Target price is lower than the current share price.


Discover undervalued companies